Gerresheimer Ag · XETR:GXI
Gerresheimer — Investor Day (September 2010)
20 slides from Gerresheimer's investor day presentation, Sep 1, 2010
Slide 1: Gerresheimer Capital Markets Day 2010: Gerresheimer Today
Gerresheimer CAPITAL MARKETS DAY 2010 Gerresheimer Today September 1, 2010 Uwe Röhrhoff, CEO
Slide 2: Gerresheimer – who we are and what we do
Gerresheimer – who we are and what we do Gerresheimer is an important partner of the pharmaceutical and healthcare industry. Innovations in the application of pharmaceutical products are innovations that people benefit from and which improve their quality of life. Our products make a practical
Slide 3: Gerresheimer today
Gerresheimer today 1 Products 2 Markets 3 Customers 4 Technologies 5 Organization 3
Slide 4: Pharmaceutical Packaging products
1 Products Pharmaceutical Packaging products Glass Plastics Ampoules Cartridges Containers for Liquid Drugs Vials Pharma Bottles Containers for Solid Drugs 4
Slide 5: Pharmaceutical Systems & Medical Devices
1 Products Pharmaceutical Systems & Medical Devices Pharmaceutical Systems Medical Devices ACCU-CHEK® Multiclix Turbuhaler (AstraZeneca) (Roche Diagnostics) Flexpen(Novo Nordisk) ACCU-CHEK® Mobile FastClix Novolizer (MEDA Pharma) RTF® Syringes and its components (Roche Diagnostics) 5
Slide 6: Products for adjacent markets
1 Products Products for adjacent markets Cosmetics Life Science Research Perfumery Flacons Reusable Glassware Jars etc. for Care Products Disposable Glassware 6
Slide 7: Leading market positions in attractive niche markets
2 Markets Leading market positions in attractive niche markets Tubular Glass Plastic Systems Life Moulded Division (Injectable Glass (Plastic Drug Delivery Science Glass and Systems) and Systems) Research Inha- Diabetes OTC Liquids Glass Other Plastic Product Tubing Syringes Injectables Packaging la
Slide 8: Well-diversified blue-chip customer base
3 Customers Well-diversified blue-chip customer base Net revenues to Top 50 customers Pharma & Healthcare Other (FY 2009) in EUR m 359 61% 58% 53% Cumulative 46% share 36% 105 65 48 32 Top 10 11-20 21-30 31-40 41-50 Gerresheimer has close long-term relationships …with limited dependence on individua
Slide 9: Technologically leading. Strategically focused. Globally active.
3 Customers Technologically leading. Strategically focused. Globally active. Consolidated net revenues FY 2009: EUR 1,000.2m Revenues by market segment Revenues by region Europe 66% Pharma & Healthcare 80% Cosmetics 11% Americas 28% Other 9% China 2% Other 4% 9
Slide 10: Breadth of products requires range of technologies
4 Technologies Breadth of products requires range of technologies Consolidated net revenues FY 2009: EUR 1,000.2m EUR 302.9m; 30% EUR 314.9m; 31% EUR 307.9m; 31% 87.4m; 8% Tubular Glass Plastic Systems Moulded Glass Life Science Research 10
Slide 11: Gerresheimer's core technologies – an overview
4 Technologies Gerresheimer’s core technologies – an overview Tubular Glass Technology Medical Plastic Systems Technology Plastic Packaging Technology Moulded Glass Technology 11
Slide 12: Tube drawing technology
4 Technologies Tube drawing technology Proprietary technologies: Furnace design Furnace control Forming technologies Inspection technology Automatic packaging Barriers to entry: Proprietary technologies Specialized process know-how Capital requirements 12
Slide 13: Tubular Glass converting technology
4 Technologies Tubular Glass converting technology Proprietary technologies: High speed vial and cartridge lines Inspection technology Barriers to entry: Proprietary technologies Specialized process know-how GMP production and regulatory know-how 13
Slide 14: RTF Syringe processing technology
4 Technologies RTF® Syringe processing technology Proprietary technologies: Gluing of needles for syringes Glass surface treatments Assembly line, including safety components Barriers to entry: Proprietary technologies GMP production + regulatory know- how similar to pharma production
Slide 15: Medical Plastic Systems injection moulding and assembly technology
4 Technologies Medical Plastic Systems injection moulding and assembly technology Proprietary technologies: Tool and product design Automation Inspection technology Barriers to entry: Proprietary technologies Product development Engineering know-how GMP production and validation kn
Slide 16: Plastic Packaging blow moulding and injection blow moulding technology
4 Technologies Plastic Packaging blow moulding and injection blow moulding technology Proprietary technologies: Product design Automation Barriers to entry: GMP production and regulatory know-how 16
Slide 17: Moulded Glass technology
4 Technologies Moulded Glass technology Proprietary technologies: Mould design Furnace design Furnace control Forming machine technology Surface treatment Barriers to entry: Proprietary technologies Specialized process know-how Capital requirements GMP production and regulatory
Slide 18: Management Board Gerresheimer
5 Organization Management Board Gerresheimer Uwe Röhrhoff Hans-Jürgen Wiecha (CEO) (CFO) Dr. Max Raster Andreas Schütte Strategy & Corp. Planning Finance Tubular Glass Plastic Systems Corp. Comm. & Marketing Controlling Life Science Research Plastic Packaging HR IR Legal IT Medical Plastic Systems C
Slide 19: Gerresheimer is a global player
5 Organization Gerresheimer is a global player Region Locations Employees Europe 19 5,166 Americas 14 2,888 Asia 7 1,409 Total 40 9,463 As of May 31, 2010 19
Slide 20: How do we manage our business?
5 Organization How do we manage our business? Local decision-making: Full profit and balance sheet responsibility Local customer service Technical Competence Centers Central decision-making: Financial targets and controlling Continuous improvement embedded in Gerresheimer Management Sy